Breakthrough sleep apnea medication AD109 shows promising results in phase 3 trials, potentially helping 30 million Americans with the condition.

Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to ...

It could be a game-changer for the millions of Americans who suffer from sleep apnea. A new first-of-its-kind pill could ...

If you have obstructive sleep apnea (OSA)—a condition that causes a partial or complete collapse of your upper airway while sleeping—you’re likely familiar with continuous positive airway pressure ...

A nightly oral pill for obstructive sleep apnea is close to regulatory approval in the US. This medicine-based option could ...

Experts reveal symptoms that strike during nighttime rest and what those signs might mean for your health.

Low-sodium oxybate reduces 24-hour sleep duration and daytime napping in adults with idiopathic hypersomnia, according to a phase 3 trial analysis.

Respiratory and sleep medicine physicians share collaborative measures to diagnose and treat comorbid sleep disorders and ...

Sleep apnea is a common sleep disorder that affects more than 20 percent of people in the United States. It happens when your breathing temporarily stops while you sleep. Depending on the severity of ...

Exercise can help reduce insomnia, although not necessarily within a few hours before sleep. Developing a relaxing evening routine that includes soothing activities as bedtime approaches is a good way ...

Sleep apnea is a common sleep disorder that affects millions of people worldwide. It is characterized by episodes of interrupted breathing during sleep, which can lead to loud snoring, disrupted sleep ...

Insomnia and other common sleep impacts in CSU improve with biologic medication ...